U.S. flag

An official website of the United States government

NM_000539.3(RHO):c.936+1G>T AND Retinitis pigmentosa 4

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Sep 1, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001265165.2

Allele description [Variation Report for NM_000539.3(RHO):c.936+1G>T]

NM_000539.3(RHO):c.936+1G>T

Gene:
RHO:rhodopsin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q22.1
Genomic location:
Preferred name:
NM_000539.3(RHO):c.936+1G>T
HGVS:
  • NC_000003.12:g.129532773G>T
  • NG_009115.1:g.9135G>T
  • NM_000539.3:c.936+1G>TMANE SELECT
  • NC_000003.11:g.129251616G>T
Nucleotide change:
IVS4AS, G-T, +1
Links:
OMIM: 180380.0026; dbSNP: rs776014770
NCBI 1000 Genomes Browser:
rs776014770
Molecular consequence:
  • NM_000539.3:c.936+1G>T - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:
Retinitis pigmentosa 4 (RP4)
Synonyms:
RP 4; RETINITIS PIGMENTOSA, RHODOPSIN-RELATED
Identifiers:
MONDO: MONDO:0013395; MedGen: C3151001; Orphanet: 791; OMIM: 613731

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000034161OMIM
no assertion criteria provided
Pathogenic
(Oct 19, 2017)
germlineliterature only

Rosenfeld, P. J., Cowley, G. S., Hahn, L. B., Sandberg, M. A., Berson, E. L., Dryja, T. P. A null mutation within the rhodopsin gene in a family with autosomal recessive retinitis pigmentosa. (Abstract) Invest. Ophthal. Vis. Sci. 33: 1397, 1992.,

SCV001443252Centre for Genomic Medicine, Manchester, Central Manchester University Hospitals
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Sep 1, 2020)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineyes2not providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From OMIM, SCV000034161.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature onlynot provided

Description

In screening a group of 117 control persons without RP for the nonsense mutation E249X (180380.0023) in the RHO gene, Rosenfeld et al. (1992) found a 28-year-old female who was heterozygous for a different potential null mutation. After detection by SSCP analysis, direct sequencing of polymerase chain reaction (PCR)-amplified DNA from this person revealed a heterozygous G-to-T substitution at position 4335 within intron 4 of the rhodopsin gene. Since it is located at the canonical GT of the first 2 nucleotides of the splice donor sequence, the mutation is expected to interfere with normal processing of intron 4 and thus could alter the carboxy-terminal 36 amino acids of the rhodopsin molecule. The woman was found to have a reduction in rod sensitivity that was similar to the decrease observed in the carriers of the E249X mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Centre for Genomic Medicine, Manchester, Central Manchester University Hospitals, SCV001443252.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided2not providednot providednot provided

Last Updated: Sep 29, 2024